PHILADELPHIA — The newly approved varicella vaccine, Varivax®, should be universally used in early childhood and for susceptible older children and adolescents, AAP leaders announced at the 1995 AAP Spring Session.

"The American Academy of Pediatrics recommends the varicella vaccine for all children, adolescents and young adults who have not already been infected with chickenpox," AAP Committee on Infectious Diseases member Neal Halsey., M.D., said at the April meeting. "Our reason for this is three-fold: The serious complications and deaths that can result from chickenpox, the cost to families and society in terms of lost work days, and the efficiency and safety of the new varicella vaccine."

This content is only available via PDF.
You do not currently have access to this content.